MODALITY
saveBispecific Antibody
Antibody binding two targets simultaneously.
also known as: bsab, bispecific
drugs
0
catalysts
0
news
440
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier assetbiospace · 11h ago
- Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engagerfiercebiotech · 3d ago
- Sanofi pays Regeneron $1B upfront to continue search for Dupixent successorbiospace · 4d ago
- Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&Dfiercebiotech · 4d ago
- AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a rollbiospace · 5d ago
- STAT+: AstraZeneca invests $2 billion in Summit Therapeuticsstat · 6d ago
- Summit snags $2B investment from AstraZeneca, clearing financial overhangbiospace · 6d ago
- Spark co-founder Steven Altschuler is back with an immune-resetting biotechendpoints · 6d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that